Fountain SJ - Search Results

1

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.

Illes P, Müller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F. Illes P, et al. Among authors: fountain sj. Br J Pharmacol. 2021 Feb;178(3):489-514. doi: 10.1111/bph.15299. Epub 2020 Dec 21. Br J Pharmacol. 2021. PMID: 33125712 Free PMC article. Review.

2

A mechanism of intracellular P2X receptor activation.

Sivaramakrishnan V, Fountain SJ. Sivaramakrishnan V, et al. Among authors: fountain sj. J Biol Chem. 2012 Aug 17;287(34):28315-26. doi: 10.1074/jbc.M112.372565. Epub 2012 Jun 26. J Biol Chem. 2012. PMID: 22736763 Free PMC article.

3

P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology.

Stokes L, Layhadi JA, Bibic L, Dhuna K, Fountain SJ. Stokes L, et al. Among authors: fountain sj. Front Pharmacol. 2017 May 23;8:291. doi: 10.3389/fphar.2017.00291. eCollection 2017. Front Pharmacol. 2017. PMID: 28588493 Free PMC article. Review.

4

P2Y₁₂ receptor modulation of ADP-evoked intracellular Ca²⁺ signalling in THP-1 human monocytic cells.

Micklewright JJ, Layhadi JA, Fountain SJ. Micklewright JJ, et al. Among authors: fountain sj. Br J Pharmacol. 2018 Jun;175(12):2483-2491. doi: 10.1111/bph.14218. Epub 2018 Apr 29. Br J Pharmacol. 2018. PMID: 29574692 Free PMC article.

5

Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation.

Richards D, Gever JR, Ford AP, Fountain SJ. Richards D, et al. Among authors: fountain sj. Br J Pharmacol. 2019 Jul;176(13):2279-2291. doi: 10.1111/bph.14677. Epub 2019 May 11. Br J Pharmacol. 2019. PMID: 30927255 Free PMC article.

6

Inhibitors of DAG metabolism suppress CCR2 signalling in human monocytes.

Day P, Burrows L, Richards D, Fountain SJ. Day P, et al. Among authors: fountain sj. Br J Pharmacol. 2019 Aug;176(15):2736-2749. doi: 10.1111/bph.14695. Epub 2019 Jun 17. Br J Pharmacol. 2019. PMID: 31032885 Free PMC article.

7

Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.

Gonzalez-Montelongo MDC, Fountain SJ. Gonzalez-Montelongo MDC, et al. Among authors: fountain sj. Vascul Pharmacol. 2021 Feb;136:106810. doi: 10.1016/j.vph.2020.106810. Epub 2020 Nov 9. Vascul Pharmacol. 2021. PMID: 33181321

8

Taspine is a natural product that suppresses P2X4 receptor activity via phosphoinositide 3-kinase inhibition.

Nadzirin IB, Fortuny-Gomez A, Ngum N, Richards D, Ali S, Searcey M, Fountain SJ. Nadzirin IB, et al. Among authors: fountain sj. Br J Pharmacol. 2021 Dec;178(24):4859-4872. doi: 10.1111/bph.15663. Epub 2021 Sep 21. Br J Pharmacol. 2021. PMID: 34398973 Free article.

9

An intracellular P2X receptor required for osmoregulation in Dictyostelium discoideum.

Fountain SJ, Parkinson K, Young MT, Cao L, Thompson CR, North RA. Fountain SJ, et al. Nature. 2007 Jul 12;448(7150):200-3. doi: 10.1038/nature05926. Nature. 2007. PMID: 17625565 Free PMC article.

10

Permeation properties of a P2X receptor in the green algae Ostreococcus tauri.

Fountain SJ, Cao L, Young MT, North RA. Fountain SJ, et al. J Biol Chem. 2008 May 30;283(22):15122-6. doi: 10.1074/jbc.M801512200. Epub 2008 Apr 1. J Biol Chem. 2008. PMID: 18381285 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page